Comparsion of IV Dexmedetomidine, Tramdol and Ketamine for Post Spinal Anesthesia Shivering.

Ketamine

Brief Summary

To study control of post spinal shivering in patients undergoing lower segment cesarean section using dexmedetomidine, tramadol and ketamine

Intervention / Treatment

3 drugs were given to patients
  • Dexmedetomidine (DRUG)
    Inj dexmedetomidine, will be given in infusion over 10 mins and their effect on post spinal shivering will be assessed.
  • Ketamine (DRUG)
  • Tramadol (DRUG)

Condition or Disease

  • Post-Surgical Complication

Phase

  • Phase 3

    • Study Design

    Study type: INTERVENTIONAL
    Status: Not yet recruiting
    Study results: No Results Available
    Age: 18 Years to 60 Years
    Enrollment: 71 (ESTIMATED)
    Allocation: Randomized
    Primary Purpose: Health Services Research

    Masking

    SINGLE:
    • Participant

    Clinical Trial Dates

    Start date: Apr 30, 2022 ESTIMATED
    Primary Completion: Dec 31, 2022 ESTIMATED
    Completion Date: Feb 20, 2023 ESTIMATED
    Study First Posted: Apr 05, 2022 ACTUAL
    Last Updated: Apr 04, 2022

    Sponsors / Collaborators

    Lead Sponsor: N/A
    Responsible Party: N/A

    Its a Comparison of drugs for a better control of post spinal shivering in patietns underwent cesarean section.using grades of shivering (0-4)patients will be assessed

    Participant Groups

    • Inj.dexmedetomidine 0.5mcg/kg diluted in 10ml N/s given as iv infusion over 10 minutes

    • Inj.ketamine 0.5mg/kg diluted in 10ml N/s given as iv infusion over 10 minutes

    • Inj.tramadol 0.5mg/kg diluted in 10ml N/s given as iv infusion over 10 minutes

    Eligibility Criteria

    Sex: Female
    Minimum Age: 18
    Maximum Age: 60
    Age Groups: Adult
    Healthy Volunteers: Yes

    Inclusion Criteria:

    * Woman of age 18-60
    * Pregnant woman in outdoor patient department and emergency

    Exclusion Criteria:

    * patient. with history of hypersensitivity to opioids,
    * ketamine or bupivacaine
    * History of cardiovascular disease,
    * Hypertension,
    * psychosis,
    * antepartum hemorrhage,
    * cord prolapse,
    * fetal distress

    Primary Outcomes

    • Control of post spinal shivering dexmedetomidine, tramadol and ketamine for control of post spinal shivering.

    More Details

    NCT Number: NCT05311722
    Other IDs: ORehman
    Study URL: https://clinicaltrials.gov/study/NCT05311722
    Last updated: Sep 29, 2023